BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23754791)

  • 1. Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.
    Radhakrishnan P; Grandgenett PM; Mohr AM; Bunt SK; Yu F; Chowdhury S; Hollingsworth MA
    Int J Cancer; 2013 Dec; 133(12):2824-33. PubMed ID: 23754791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex.
    Lee SH; Hatakeyama S; Yu SY; Bao X; Ohyama C; Khoo KH; Fukuda MN; Fukuda M
    J Biol Chem; 2009 Jun; 284(25):17157-17169. PubMed ID: 19395705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
    Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
    Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes.
    Beum PV; Singh J; Burdick M; Hollingsworth MA; Cheng PW
    J Biol Chem; 1999 Aug; 274(35):24641-8. PubMed ID: 10455130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
    Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM
    Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
    Suzuki Y; Sutoh M; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Habuchi T; Arai Y; Fukuda M; Ohyama C; Tsuboi S
    Int J Oncol; 2012 Jun; 40(6):1831-8. PubMed ID: 22446589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function.
    Bassagañas S; Carvalho S; Dias AM; Pérez-Garay M; Ortiz MR; Figueras J; Reis CA; Pinho SS; Peracaula R
    PLoS One; 2014; 9(5):e98595. PubMed ID: 24878505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
    Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
    Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the biological functions of mucin type core 3 O-glycans.
    Lee SH; Fukuda M
    Methods Mol Biol; 2013; 1022():41-50. PubMed ID: 23765652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
    Premaratne P; Welén K; Damber JE; Hansson GC; Bäckström M
    Tumour Biol; 2011 Feb; 32(1):203-13. PubMed ID: 20872286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.
    Ho WL; Che MI; Chou CH; Chang HH; Jeng YM; Hsu WM; Lin KH; Huang MC
    Cancer Sci; 2013 Dec; 104(12):1600-8. PubMed ID: 24118321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
    Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
    Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration.
    Isaji T; Gu J; Nishiuchi R; Zhao Y; Takahashi M; Miyoshi E; Honke K; Sekiguchi K; Taniguchi N
    J Biol Chem; 2004 May; 279(19):19747-54. PubMed ID: 14998999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
    Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
    Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion.
    Isaji T; Kariya Y; Xu Q; Fukuda T; Taniguchi N; Gu J
    Methods Enzymol; 2010; 480():445-59. PubMed ID: 20816221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
    PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
    Iwai T; Kudo T; Kawamoto R; Kubota T; Togayachi A; Hiruma T; Okada T; Kawamoto T; Morozumi K; Narimatsu H
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4572-7. PubMed ID: 15755813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
    Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
    PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.